Exane Derivatives’s Snap-on SNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$65K Sell
330
-39
-11% -$8.31K 0.04% 296
2022
Q1
$75.8K Buy
369
+28
+8% +$5.91K 0.02% 510
2021
Q4
$73.4K Buy
341
+16
+5% +$3.42K 0.02% 463
2021
Q3
$67.9K Sell
325
-86
-21% -$19.1K 0.02% 588
2021
Q2
$91.9K Sell
411
-165
-29% -$39.5K 0.02% 551
2021
Q1
$133K Sell
576
-59
-9% -$11.6K 0.04% 364
2020
Q4
$109K Buy
635
+455
+253% +$76.1K 0.03% 385
2020
Q3
$26.5K Hold
180
0.01% 411
2020
Q2
$24.9K Hold
180
0.01% 392
2020
Q1
$19.6K Hold
180
0.01% 407
2019
Q4
$30.1K Hold
180
0.01% 381
2019
Q3
$28.2K Buy
180
+17
+10% +$2.61K 0.01% 389
2019
Q2
$27K Sell
163
-1
-0.6% -$163 ﹤0.01% 415
2019
Q1
$25.7K Sell
164
-85
-34% -$13.5K 0.01% 368
2018
Q4
$36.2K Hold
249
0.01% 393
2018
Q3
$45.8K Buy
+249
New +$43.4K 0.01% 374

Other funds holding SNA

Exane Derivatives's SNA Position: Q2 2022 in Review

Exane Derivatives reduced its Snap-on (SNA) stake by 11% in Q2 2022, selling an estimated $8.31K and leaving 330 shares worth $65K. The position accounts for 0.04% of the portfolio, ranked #296.

Exane Derivatives first reported a position in SNA in Q3 2018 and has held it in 16 quarters since. The position peaked at $133K in Q1 2021. 711 funds tracked by Wall St. Rank hold SNA as of Q2 2022.

  • Exane Derivatives held 330 shares of Snap-on worth $65K as of Q2 2022.
  • Exane Derivatives sold 39 Snap-on shares in Q2 2022, an estimated $8.31K.
  • Snap-on made up 0.04% of Exane Derivatives's portfolio in Q2 2022, its #296 holding.
  • Exane Derivatives first reported a position in Snap-on in Q3 2018 and has held it in 16 quarters since.
  • Exane Derivatives's Snap-on position peaked at $133K in Q1 2021.
  • 711 funds tracked by Wall St. Rank held Snap-on as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.